Exosens Shares Drop 4.08% to €57.60, Entering Oversold Territory
Exosens stock fell by 4.08% to €57.60 at midday this Monday, within an SBF 120 that dropped by 0.82% to 6,115.66 points. The specialist in night vision and imaging technologies for defense is among the top 5 biggest losers in the index. The decline intensifies even as the stock still maintains a 65% gain over the year.
Below the Lower Bollinger Band, RSI at 39
Today's movement pushes Exosens below the lower boundary of its Bollinger Bands, set at €60.55. This configuration signals a potential oversold condition, with the price now about 5% below this lower limit. An RSI at 39 confirms selling pressure without reaching the classic oversold zone. The stock is significantly below its 20-day and 50-day moving averages, located at €64.19 and €64.55 respectively, with a gap of more than 10% for each. The 200-day average, at €51.04, remains 12.85% below the price, indicating that the long-term trend is not compromised. The technical support is at €57.50, a level at which the stock is currently trading. The resistance of €67.10 is moving away mechanically.
Tight Valuation Ahead of the General Meeting
Based on analyst consensus, the stock is trading at about 30.6 times the expected earnings for the current fiscal year and 25.9 times those of the following year, with an estimated earnings per share growth of 18.4% between the two periods. These multiples compare to an industry average of around 18.4 times. The stock market sequence remains heavy after last week's decline, when the stock had dropped below €60 on Friday. As a reminder, the company reported a 19.7% increase in revenue to €122.6 million for the first quarter of 2026, announced on April 29. The next key event on the calendar is the annual general meeting scheduled for May 22, 2026, followed by the semi-annual results on July 28.
